Stopping medical research to save money: a broken pact with researchers and patients

JAMA. 2003 Apr 23-30;289(16):2128-31. doi: 10.1001/jama.289.16.2128.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Benzothiadiazines
  • Calcium Channel Blockers / therapeutic use
  • Clinical Trials as Topic / economics*
  • Clinical Trials as Topic / ethics
  • Clinical Trials as Topic / standards*
  • Diuretics
  • Drug Industry / economics*
  • Drug Industry / ethics
  • Drug Industry / standards*
  • Humans
  • Hypertension / drug therapy
  • Outcome Assessment, Health Care
  • Sodium Chloride Symporter Inhibitors / therapeutic use
  • Vasodilator Agents / therapeutic use
  • Verapamil / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Benzothiadiazines
  • Calcium Channel Blockers
  • Diuretics
  • Sodium Chloride Symporter Inhibitors
  • Vasodilator Agents
  • Verapamil